🔗 Permalink

Assignee profile:

Lennham Pharmaceuticals, Inc.

City:

Concord, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2025-08-07

Patent Grants:

Last grant date:

2024-09-17

Top Inventors for applications by Lennham Pharmaceuticals, Inc.

These are the the leading inventors for applications assigned to Lennham Pharmaceuticals, Inc.:

BRADFORD C. SIPPY 12 Acton, MA United States
Benjamin D. Enerson 4 Sudbury, MA United States
Bradford Sippy 1 Acton, MA United States

Recent patent applications by Lennham Pharmaceuticals, Inc.

Lennham Pharmaceuticals, Inc. based in Concord, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-08-07

US20250248424A1

Human necessities

DEUTERATED CAFFEINE AND USES THEREOF

#2 | 2024-12-12

US20240409405A1

Chemistry; metallurgy

PRODUCTS COMPRISING DEUTERIUM-ENRICHED WATER

#3 | 2024-01-04

US20240000799A1

Human necessities

DEUTERATED FORMS OF TESTOSTERONE AND METHODS OF USE

#4 | 2023-11-23

US20230371555A1

Human necessities

DEUTERATED CAFFEINE AND USES THEREOF

#5 | 2023-11-09

US20230355632A1

Human necessities

DEUTERATED PARAXANTHINE AND USES THEREOF

#6 | 2023-04-20 ✅ Patent 12,090,159 granted on 2024-09-17

US20230124138A1

Human necessities

Deuterated forms of testosterone and methods of use

#7 | 2022-09-15 ✅ Patent 12,194,046 granted on 2025-01-14

US20220288083A1

Human necessities

D9-caffeine compositions and uses thereof

#8 | 2022-08-11 ✅ Patent 11,666,073 granted on 2023-06-06

US20220248720A1

Human necessities

Deuterated caffeine and uses thereof

#9 | 2022-07-21 ✅ Patent 11,547,127 granted on 2023-01-10

US20220225642A1

Human necessities

Deuterated caffeine and uses thereof

#10 | 2022-06-09 ✅ Patent 11,471,469 granted on 2022-10-18

US20220175796A1

Human necessities

Deuterated forms of testosterone and methods of use

#11 | 2022-05-31 ✅ Patent 11,344,564 granted on 2022-05-31

US17554003

Human necessities

Method of treatment based on reduced monoamine oxidase a activity

#12 | 2022-05-26 ✅ Patent 11,633,371 granted on 2023-04-25

US20220160660A1

Human necessities

Deuterated forms of acetaminophen and uses thereof

#13 | 2022-04-14 ✅ Patent 11,324,762 granted on 2022-05-10

US20220110956A1

Human necessities

Deuterated derivatives of psilocybin and uses thereof

Also check out Lennham Pharmaceuticals, Inc.'s (Concord, United States) applicant profile with 10 patent applications submitted.

AssigneeID:

324056 ⎘